Ledger.Open graph →
SEC Form D · filed November 18, 2022

MBX Biosciences, Inc

Offering
$115.2M
Sold
$46.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CARMEL, IN
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Peter K. Hawryluk · Carmel, INExec · DirectorRichard K. Dimarchi · Carmel, INExec · DirectorTiba M. Aynechi · Carmel, INDirectorChristoph Janz · Brooklyn, NYExec · DirectorJoshua Buckley · Brooklyn, NYExec · DirectorJames M. Cornelius · Indianapolis, INDirectorPatrick M. Heron · Carmel, INDirectorEdward M. Mathers · Carmel, INDirectorOra K. Pescovitz · Carmel, INDirectorCarl M. Gordon · Carmel, INDirectorRichard M. Bartram · Carmel, INExecJames F. Connor · Menlo Park, CAExec · DirectorFrederick Brumder · Bend, ORExec · DirectorJames M. Cornelius · Carmel, INDirectorPatrick M. Heron · Carmel, INDirectorEdward M. Mathers · Carmel, INDirectorTiba M. Aynechi · Carmel, INDirectorOra K. Pescovitz · Carmel, INDirectorCarl M. Gordon · Carmel, INDirectorRichard M. Bartram · Carmel, INExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗